Skip to main content

Table 3 Multivariate COX regression analysis: Patient survival was analysed by multivariate COX regression analysis

From: Immunosuppressive Glycodelin A is an independent marker for poor prognosis in endometrial cancer

   95% CI  
Covariate Coefficient (bi) [HR Exp(bi)] Lower Upper P-value
FIGO stage      <0.001
I (0.000) (1.00)    
II −3.064 .047 .011 .192 <0.001
III −3.025 .049 .010 .233 <0.001
IV −1.810 .164 .040 .669 .012
WHO grade      .023
1 (0.000) (1.00)    
2 −.820 .440 .246 .790 .006
3 −.561 .571 .325 1.002 .051
Histology      0.068
Endometrioid (0.000) (1.00)    
Serous −.297 .743 .233 2.372 .616
Clear cell −.069 .934 .260 3.349 .916
Mucinous −1.423 .241 .024 2.403 .225
Squamous cell .074 1.077 .260 4.470 .918
Mixed cell 3.167 23.742 2.245 251.079 .008
Undifferentiated −.163 .850 .255 2.828 .790
Lymph node metastasis −.732 .481 .209 1.109 .086
Age (≤50 y vs. >50 y) 1.939 6.953 .909 53.204 .062
Diabetes .451 1.570 .880 2.800 .127
Obesity −.065 .937 .600 1.462 .774
Hypertension .454 1.575 1.043 2.380 .031
Lymphangiosis .216 1.241 .631 2.443 .532
Hemangiosis .681 1.975 .476 8.187 .348
ER alpha −.031 .970 .652 1.442 .880
PRA −.156 .855 .572 1.279 .446
GdA .840 2.317 1.362 3.943 .002
Gd −.298 .743 .456 1.209 .232
  1. Significant results are shown in bold.